>
CIA Analyst Larry Johnson: US and Iran Back at War! What Happens Next? LIVE
Scott Ritter's Shocking Report From Inside Russia
Regenerative Farming Executive Order
Bill C-8 IS NOW LAW: Canada's WARRANTLESS SURVEILLANCE NIGHTMARE Explained!!
'Groundbreaking' Potential Lupus Cure Sends Patients into Remission, Allowing Dreams...
Speculations on What Could Show Physics Beyond the Standard Model
SpaceX Orbital Travel and Orbital Hotels Need Starfall – Getting Back Safe and Cheap is Exciting
Lizard-inspired wiggly wheels let Mars rover swim through sand
Fact Sheet: President Donald J. Trump Ushers in the Next Frontier of Quantum Innovation
Researchers at Johns Hopkins University just let an AI-guided robot remove a dead pig's gallblad
World's first consumer wing-in-ground effect aircraft takes flight
America's Military Readiness Depends On Deployable Nuclear Power
License Plate Cameras Are About To Start Tracking A Lot More Than Just Your Car
Heads up: Apparently the government is hiding cameras inside fake utility boxes

Epidemiologist Nicolas Hulscher on Brannon Howse Live
Yesterday, I joined Brannon Howse Live to share some long-overdue good news. We discussed emerging breakthroughs in cancer research, the extraordinary promise of natural compounds like dandelion root and high-dose vitamin C, and a major development in the mRNA arena:
Dandelion Root Extract: A Common Weed With Anti-Cancer Power
·
Dec 9
A remarkable peer-reviewed study found that aqueous dandelion root extract kills 95% of cancer cells in vitro and reduces human colon tumor growth by over 90% in mice — with zero toxicity.
Tumors in untreated mice grew aggressively.
Tumors in the treated group barely grew at all.
Human trials were planned but mysteriously never funded — likely because a common backyard plant is not profitable for the chemo-industrial complex.
This study fits into a larger body of over 1,100 peer-reviewed papers showing anti-cancer effects from natural, non-toxic compounds — an entire therapeutic frontier long ignored because it threatens the economics of conventional oncology.